Share Price and Basic Stock Data
Last Updated: November 4, 2025, 6:26 pm
| PEG Ratio | 4.25 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Aplab Ltd operates in the instrumentation and process control industry, with its shares currently priced at ₹85.3 and a market capitalization of ₹192 Cr. The company reported a total sales figure of ₹51.48 Cr for the fiscal year ending in March 2023, declining marginally from ₹51.36 Cr in March 2022. However, the trailing twelve months (TTM) sales stood at ₹69.18 Cr, indicating a recovery trend. Quarterly sales figures showed fluctuations, with the highest quarterly sales of ₹18.49 Cr recorded in March 2023, followed by a drop to ₹9.11 Cr in June 2023. The sales trajectory demonstrates volatility, with significant peaks and troughs that may reflect market demand and operational challenges. Aplab’s operating profit margin (OPM) was reported at 11.26%, suggesting that while the company has maintained some level of profitability, the variability in sales raises questions about its revenue stability and long-term growth potential.
Profitability and Efficiency Metrics
The profitability metrics for Aplab Ltd indicate a challenging financial landscape. The reported net profit for the fiscal year ending March 2023 was ₹1.01 Cr, translating to an earnings per share (EPS) of ₹0.10, which is relatively low. The company’s return on equity (ROE) stood at 2.95%, significantly below the typical sector range, indicating underperformance in generating returns for shareholders. Moreover, the interest coverage ratio (ICR) was recorded at -0.39x, reflecting difficulties in meeting interest obligations from operating profits. The cash conversion cycle (CCC) was notably high at 219.18 days, which could signal inefficiencies in managing receivables, inventory, and payables. Despite some positive trends in operating profit in specific quarters, the overall profitability metrics pose concerns about Aplab’s operational efficiency and financial health, especially in a competitive industry.
Balance Sheet Strength and Financial Ratios
Aplab Ltd’s balance sheet reveals some stress indicators, notably with total borrowings amounting to ₹29.93 Cr against reserves of ₹-2.19 Cr. This negative reserves position highlights potential solvency issues, as the company has more liabilities than net assets. The price-to-book value (P/BV) ratio stood at -2.24x, indicating that the market values Aplab’s equity at a significant discount, likely reflecting investor skepticism regarding its financial stability. The company’s current ratio was not reported, but an analysis of the working capital days indicates a slight improvement in liquidity management, with a figure of -17.26 days for March 2025. The ROCE of 8.82% suggests that the company is generating returns on its capital employed, albeit modestly. The financial ratios indicate that while Aplab has operational capabilities, its balance sheet is under pressure, necessitating a strategic review to enhance financial resilience.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Aplab Ltd shows a significant presence of public shareholders, who held 56.16% of the total shares as of the latest report. Promoters own 43.83% of the company, a stable figure that has seen some fluctuations in recent quarters, peaking at 67.61% in December 2024 before declining. The low institutional investment, with domestic institutional investors (DIIs) holding only 0.01%, reflects a lack of confidence from larger investors in Aplab’s prospects. The total number of shareholders increased to 5,619, indicating some level of interest from retail investors. However, the high promoter ownership could raise concerns about governance and minority shareholder rights. Overall, while the public’s involvement may suggest interest, the significant promoter stake and low institutional backing may deter larger investments, impacting future capital-raising efforts.
Outlook, Risks, and Final Insight
The outlook for Aplab Ltd is tenuous, with several risks and strengths evident from the reported data. On the positive side, the recovery in TTM sales to ₹69.18 Cr and a relatively stable operating profit margin are encouraging signs. However, significant risks remain, including the company’s negative reserves, high debt levels, and poor interest coverage, which could impact its ability to sustain operations during economic downturns. Additionally, the high cash conversion cycle points to operational inefficiencies that could hinder growth. Moving forward, Aplab must address its balance sheet weaknesses and enhance operational efficiency to regain investor confidence. If the company can stabilize its revenues and improve profitability metrics, it may attract more institutional investment and potentially improve its market standing. In contrast, failure to address these issues could lead to further declines in shareholder value and operational viability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Aplab Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Aplab Ltd | 199 Cr. | 87.0 | 88.8/28.2 | 183 | 7.53 | 0.00 % | 8.82 % | 2.95 % | 10.0 |
| Industry Average | 199.00 Cr | 87.00 | 183.00 | 7.53 | 0.00% | 8.82% | 2.95% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.89 | 10.56 | 11.54 | 18.49 | 9.11 | 10.88 | 11.93 | 17.61 | 9.93 | 13.86 | 15.94 | 23.93 | 15.45 |
| Expenses | 12.12 | 11.49 | 10.54 | 11.27 | 8.34 | 9.34 | 11.19 | 15.88 | 9.10 | 13.26 | 23.94 | 25.33 | 13.71 |
| Operating Profit | -1.23 | -0.93 | 1.00 | 7.22 | 0.77 | 1.54 | 0.74 | 1.73 | 0.83 | 0.60 | -8.00 | -1.40 | 1.74 |
| OPM % | -11.29% | -8.81% | 8.67% | 39.05% | 8.45% | 14.15% | 6.20% | 9.82% | 8.36% | 4.33% | -50.19% | -5.85% | 11.26% |
| Other Income | -1.44 | 0.07 | -0.41 | 0.06 | 0.06 | 0.06 | 0.05 | -0.03 | 0.06 | 1.88 | 0.46 | 2.69 | 0.19 |
| Interest | 0.67 | 0.66 | 0.75 | 0.93 | 0.67 | 1.35 | 0.33 | 1.09 | 0.67 | 0.82 | 0.77 | 0.95 | 0.68 |
| Depreciation | 0.12 | 0.12 | 0.12 | 0.08 | 0.14 | 0.11 | 0.08 | 0.12 | 0.12 | 0.13 | 0.10 | 0.13 | 0.12 |
| Profit before tax | -3.46 | -1.64 | -0.28 | 6.27 | 0.02 | 0.14 | 0.38 | 0.49 | 0.10 | 1.53 | -8.41 | 0.21 | 1.13 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,252.38% | 24.78% |
| Net Profit | -3.46 | -1.64 | -0.28 | 6.27 | 0.02 | 0.14 | 0.38 | 0.49 | 0.10 | 1.53 | -8.41 | 7.04 | 0.85 |
| EPS in Rs | -1.73 | -0.82 | -0.14 | 3.14 | 0.01 | 0.06 | 0.17 | 0.22 | 0.05 | 0.69 | -3.35 | 2.80 | 0.34 |
Last Updated: August 19, 2025, 11:35 pm
Below is a detailed analysis of the quarterly data for Aplab Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 15.45 Cr.. The value appears to be declining and may need further review. It has decreased from 23.93 Cr. (Mar 2025) to 15.45 Cr., marking a decrease of 8.48 Cr..
- For Expenses, as of Jun 2025, the value is 13.71 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.33 Cr. (Mar 2025) to 13.71 Cr., marking a decrease of 11.62 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.74 Cr.. The value appears strong and on an upward trend. It has increased from -1.40 Cr. (Mar 2025) to 1.74 Cr., marking an increase of 3.14 Cr..
- For OPM %, as of Jun 2025, the value is 11.26%. The value appears strong and on an upward trend. It has increased from -5.85% (Mar 2025) to 11.26%, marking an increase of 17.11%.
- For Other Income, as of Jun 2025, the value is 0.19 Cr.. The value appears to be declining and may need further review. It has decreased from 2.69 Cr. (Mar 2025) to 0.19 Cr., marking a decrease of 2.50 Cr..
- For Interest, as of Jun 2025, the value is 0.68 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.95 Cr. (Mar 2025) to 0.68 Cr., marking a decrease of 0.27 Cr..
- For Depreciation, as of Jun 2025, the value is 0.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.13 Cr. (Mar 2025) to 0.12 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.13 Cr.. The value appears strong and on an upward trend. It has increased from 0.21 Cr. (Mar 2025) to 1.13 Cr., marking an increase of 0.92 Cr..
- For Tax %, as of Jun 2025, the value is 24.78%. The value appears to be increasing, which may not be favorable. It has increased from -3,252.38% (Mar 2025) to 24.78%, marking an increase of 3,277.16%.
- For Net Profit, as of Jun 2025, the value is 0.85 Cr.. The value appears to be declining and may need further review. It has decreased from 7.04 Cr. (Mar 2025) to 0.85 Cr., marking a decrease of 6.19 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.34. The value appears to be declining and may need further review. It has decreased from 2.80 (Mar 2025) to 0.34, marking a decrease of 2.46.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:56 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 94.86 | 74.18 | 70.89 | 72.04 | 61.03 | 53.19 | 51.47 | 53.02 | 51.36 | 51.48 | 49.05 | 63.67 | 69.18 |
| Expenses | 82.20 | 76.93 | 76.44 | 74.36 | 65.02 | 55.68 | 47.45 | 47.75 | 44.42 | 45.27 | 44.52 | 71.64 | 76.24 |
| Operating Profit | 12.66 | -2.75 | -5.55 | -2.32 | -3.99 | -2.49 | 4.02 | 5.27 | 6.94 | 6.21 | 4.53 | -7.97 | -7.06 |
| OPM % | 13.35% | -3.71% | -7.83% | -3.22% | -6.54% | -4.68% | 7.81% | 9.94% | 13.51% | 12.06% | 9.24% | -12.52% | -10.21% |
| Other Income | 0.93 | 0.71 | 0.82 | 1.55 | 0.38 | 18.50 | 3.42 | 1.32 | -1.08 | -1.72 | 0.24 | 5.09 | 5.22 |
| Interest | 10.22 | 10.63 | 11.24 | 11.21 | 10.82 | 8.06 | 6.21 | 6.60 | 5.31 | 3.84 | 3.53 | 3.20 | 3.22 |
| Depreciation | 2.78 | 1.76 | 1.62 | 1.56 | 1.44 | 1.29 | 1.02 | 0.38 | 0.38 | 0.45 | 0.44 | 0.49 | 0.48 |
| Profit before tax | 0.59 | -14.43 | -17.59 | -13.54 | -15.87 | 6.66 | 0.21 | -0.39 | 0.17 | 0.20 | 0.80 | -6.57 | -5.54 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 18.77% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -103.96% | |
| Net Profit | 0.59 | -14.43 | -17.59 | -13.54 | -15.87 | 5.41 | 0.21 | -0.39 | 0.17 | 0.20 | 0.80 | 0.26 | 1.01 |
| EPS in Rs | 0.30 | -7.22 | -8.80 | -6.77 | -7.94 | 2.70 | 0.10 | -0.20 | 0.08 | 0.10 | 0.36 | 0.10 | 0.48 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -2545.76% | -21.90% | 23.02% | -17.21% | 134.09% | -96.12% | -285.71% | 143.59% | 17.65% | 300.00% | -67.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | 2523.86% | 44.92% | -40.23% | 151.30% | -230.21% | -189.60% | 429.30% | -125.94% | 282.35% | -367.50% |
Aplab Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 4% |
| 3 Years: | 7% |
| TTM: | 37% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 16% |
| 3 Years: | -45% |
| TTM: | -42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 61% |
| 3 Years: | 73% |
| 1 Year: | 22% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: October 10, 2025, 3:28 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 10.00 | 10.00 | 11.09 | 12.57 |
| Reserves | 21.84 | 7.02 | -10.57 | -23.03 | -37.54 | -31.64 | -31.38 | -31.08 | -30.76 | -29.81 | -3.83 | -2.19 |
| Borrowings | 74.85 | 72.78 | 71.71 | 66.30 | 70.28 | 70.20 | 71.36 | 71.71 | 47.62 | 50.24 | 28.84 | 29.93 |
| Other Liabilities | 48.83 | 42.05 | 65.49 | 70.61 | 68.55 | 59.67 | 48.54 | 43.90 | 39.54 | 45.08 | 35.24 | 29.65 |
| Total Liabilities | 150.52 | 126.85 | 131.63 | 118.88 | 106.29 | 103.23 | 93.52 | 89.53 | 66.40 | 75.51 | 71.34 | 69.96 |
| Fixed Assets | 57.68 | 55.04 | 53.33 | 51.61 | 16.78 | 4.26 | 3.70 | 3.47 | 6.54 | 7.37 | 7.03 | 6.72 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.35 | 0.82 | 2.35 | 3.59 | 3.88 | 1.08 | 0.00 | 0.49 | 1.21 |
| Investments | 2.26 | 0.07 | 0.07 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Other Assets | 90.58 | 71.74 | 78.23 | 66.90 | 88.67 | 96.60 | 86.21 | 82.16 | 58.76 | 68.12 | 63.80 | 62.00 |
| Total Assets | 150.52 | 126.85 | 131.63 | 118.88 | 106.29 | 103.23 | 93.52 | 89.53 | 66.40 | 75.51 | 71.34 | 69.96 |
Below is a detailed analysis of the balance sheet data for Aplab Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 12.57 Cr.. The value appears strong and on an upward trend. It has increased from 11.09 Cr. (Mar 2024) to 12.57 Cr., marking an increase of 1.48 Cr..
- For Reserves, as of Mar 2025, the value is -2.19 Cr.. The value appears to be improving (becoming less negative). It has improved from -3.83 Cr. (Mar 2024) to -2.19 Cr., marking an improvement of 1.64 Cr..
- For Borrowings, as of Mar 2025, the value is 29.93 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 28.84 Cr. (Mar 2024) to 29.93 Cr., marking an increase of 1.09 Cr..
- For Other Liabilities, as of Mar 2025, the value is 29.65 Cr.. The value appears to be improving (decreasing). It has decreased from 35.24 Cr. (Mar 2024) to 29.65 Cr., marking a decrease of 5.59 Cr..
- For Total Liabilities, as of Mar 2025, the value is 69.96 Cr.. The value appears to be improving (decreasing). It has decreased from 71.34 Cr. (Mar 2024) to 69.96 Cr., marking a decrease of 1.38 Cr..
- For Fixed Assets, as of Mar 2025, the value is 6.72 Cr.. The value appears to be declining and may need further review. It has decreased from 7.03 Cr. (Mar 2024) to 6.72 Cr., marking a decrease of 0.31 Cr..
- For CWIP, as of Mar 2025, the value is 1.21 Cr.. The value appears strong and on an upward trend. It has increased from 0.49 Cr. (Mar 2024) to 1.21 Cr., marking an increase of 0.72 Cr..
- For Investments, as of Mar 2025, the value is 0.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.02 Cr. (Mar 2024) to 0.03 Cr., marking an increase of 0.01 Cr..
- For Other Assets, as of Mar 2025, the value is 62.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.80 Cr. (Mar 2024) to 62.00 Cr., marking a decrease of 1.80 Cr..
- For Total Assets, as of Mar 2025, the value is 69.96 Cr.. The value appears to be declining and may need further review. It has decreased from 71.34 Cr. (Mar 2024) to 69.96 Cr., marking a decrease of 1.38 Cr..
However, the Borrowings (29.93 Cr.) are higher than the Reserves (-2.19 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -62.19 | -75.53 | -77.26 | -68.62 | -74.27 | -72.69 | -67.34 | -66.44 | -40.68 | -44.03 | -24.31 | -37.90 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 109.66 | 90.00 | 102.77 | 88.92 | 36.42 | 131.89 | 134.24 | 104.71 | 124.51 | 212.92 | 169.22 | 124.51 |
| Inventory Days | 288.61 | 275.19 | 152.39 | 102.72 | 168.84 | 184.91 | 301.69 | 243.23 | 300.66 | 544.09 | 663.21 | 193.62 |
| Days Payable | 198.46 | 103.01 | 192.21 | 18.98 | 156.27 | 152.70 | 164.50 | 167.18 | 129.08 | 194.05 | 190.71 | 98.96 |
| Cash Conversion Cycle | 199.81 | 262.18 | 62.95 | 172.66 | 48.99 | 164.11 | 271.42 | 180.76 | 296.09 | 562.96 | 641.72 | 219.18 |
| Working Capital Days | -122.51 | -170.15 | -426.01 | -462.58 | -255.08 | -276.61 | -328.98 | -320.05 | -293.58 | -194.91 | 3.13 | -17.26 |
| ROCE % | 11.00% | -4.08% | -8.40% | -4.91% | -11.74% | -8.51% | 7.41% | 13.71% | 18.98% | 21.64% | 14.91% | -8.82% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.61 |
| Diluted EPS (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.61 |
| Cash EPS (Rs.) | -31.37 | -24.41 | 7.54 | -23.24 | 1.60 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -8.81 | 26.34 | 55.53 | 47.41 | 43.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -8.77 | 26.39 | 55.59 | 47.47 | 44.03 |
| Revenue From Operations / Share (Rs.) | 142.20 | 149.14 | 191.06 | 142.68 | 194.29 |
| PBDIT / Share (Rs.) | -8.88 | -3.06 | 28.21 | -5.09 | 19.70 |
| PBIT / Share (Rs.) | -12.66 | -7.08 | 22.36 | -9.97 | 14.50 |
| PBT / Share (Rs.) | -35.14 | -28.33 | 1.91 | -28.17 | -3.48 |
| Net Profit / Share (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.59 |
| NP After MI And SOA / Share (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.59 |
| PBDIT Margin (%) | -6.24 | -2.05 | 14.76 | -3.56 | 10.13 |
| PBIT Margin (%) | -8.90 | -4.74 | 11.70 | -6.99 | 7.46 |
| PBT Margin (%) | -24.70 | -18.99 | 1.00 | -19.74 | -1.79 |
| Net Profit Margin (%) | -24.71 | -19.05 | 0.88 | -19.70 | -1.85 |
| NP After MI And SOA Margin (%) | -24.71 | -19.05 | 0.88 | -19.70 | -1.85 |
| Return on Networth / Equity (%) | 0.00 | -112.18 | 3.09 | -60.09 | -8.24 |
| Return on Capital Employeed (%) | -87.40 | -8.90 | 22.07 | -10.19 | 21.15 |
| Return On Assets (%) | -13.14 | -11.07 | 0.56 | -10.59 | -1.53 |
| Long Term Debt / Equity (X) | 0.00 | 0.58 | 0.46 | 0.57 | 0.43 |
| Total Debt / Equity (X) | -16.98 | 5.50 | 2.67 | 2.90 | 2.75 |
| Asset Turnover Ratio (%) | 0.54 | 0.53 | 0.67 | 0.57 | 0.81 |
| Current Ratio (X) | 0.39 | 0.57 | 0.67 | 0.74 | 0.96 |
| Quick Ratio (X) | 0.24 | 0.20 | 0.31 | 0.22 | 0.34 |
| Inventory Turnover Ratio (X) | 1.65 | 1.25 | 1.24 | 0.68 | 1.19 |
| Interest Coverage Ratio (X) | -0.39 | -0.14 | 1.38 | -0.27 | 1.10 |
| Interest Coverage Ratio (Post Tax) (X) | -0.56 | -0.33 | 1.08 | -0.56 | 0.80 |
| Enterprise Value (Cr.) | 88.89 | 87.10 | 88.96 | 75.60 | 70.92 |
| EV / Net Operating Revenue (X) | 1.25 | 1.17 | 0.93 | 1.06 | 0.73 |
| EV / EBITDA (X) | -20.01 | -56.88 | 6.31 | -29.70 | 7.20 |
| MarketCap / Net Operating Revenue (X) | 0.15 | 0.19 | 0.16 | 0.15 | 0.13 |
| Price / BV (X) | -2.24 | 1.16 | 0.57 | 0.45 | 0.61 |
| Price / Net Operating Revenue (X) | 0.15 | 0.19 | 0.16 | 0.15 | 0.13 |
| EarningsYield | -1.60 | -0.96 | 0.05 | -1.31 | -0.13 |
After reviewing the key financial ratios for Aplab Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 5. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For Diluted EPS (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 5. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For Cash EPS (Rs.), as of Mar 16, the value is -31.37. This value is below the healthy minimum of 3. It has decreased from -24.41 (Mar 15) to -31.37, marking a decrease of 6.96.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is -8.81. It has decreased from 26.34 (Mar 15) to -8.81, marking a decrease of 35.15.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is -8.77. It has decreased from 26.39 (Mar 15) to -8.77, marking a decrease of 35.16.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 142.20. It has decreased from 149.14 (Mar 15) to 142.20, marking a decrease of 6.94.
- For PBDIT / Share (Rs.), as of Mar 16, the value is -8.88. This value is below the healthy minimum of 2. It has decreased from -3.06 (Mar 15) to -8.88, marking a decrease of 5.82.
- For PBIT / Share (Rs.), as of Mar 16, the value is -12.66. This value is below the healthy minimum of 0. It has decreased from -7.08 (Mar 15) to -12.66, marking a decrease of 5.58.
- For PBT / Share (Rs.), as of Mar 16, the value is -35.14. This value is below the healthy minimum of 0. It has decreased from -28.33 (Mar 15) to -35.14, marking a decrease of 6.81.
- For Net Profit / Share (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 2. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 2. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For PBDIT Margin (%), as of Mar 16, the value is -6.24. This value is below the healthy minimum of 10. It has decreased from -2.05 (Mar 15) to -6.24, marking a decrease of 4.19.
- For PBIT Margin (%), as of Mar 16, the value is -8.90. This value is below the healthy minimum of 10. It has decreased from -4.74 (Mar 15) to -8.90, marking a decrease of 4.16.
- For PBT Margin (%), as of Mar 16, the value is -24.70. This value is below the healthy minimum of 10. It has decreased from -18.99 (Mar 15) to -24.70, marking a decrease of 5.71.
- For Net Profit Margin (%), as of Mar 16, the value is -24.71. This value is below the healthy minimum of 5. It has decreased from -19.05 (Mar 15) to -24.71, marking a decrease of 5.66.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is -24.71. This value is below the healthy minimum of 8. It has decreased from -19.05 (Mar 15) to -24.71, marking a decrease of 5.66.
- For Return on Networth / Equity (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -112.18 (Mar 15) to 0.00, marking an increase of 112.18.
- For Return on Capital Employeed (%), as of Mar 16, the value is -87.40. This value is below the healthy minimum of 10. It has decreased from -8.90 (Mar 15) to -87.40, marking a decrease of 78.50.
- For Return On Assets (%), as of Mar 16, the value is -13.14. This value is below the healthy minimum of 5. It has decreased from -11.07 (Mar 15) to -13.14, marking a decrease of 2.07.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.58 (Mar 15) to 0.00, marking a decrease of 0.58.
- For Total Debt / Equity (X), as of Mar 16, the value is -16.98. This value is within the healthy range. It has decreased from 5.50 (Mar 15) to -16.98, marking a decrease of 22.48.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 0.54. It has increased from 0.53 (Mar 15) to 0.54, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 16, the value is 0.39. This value is below the healthy minimum of 1.5. It has decreased from 0.57 (Mar 15) to 0.39, marking a decrease of 0.18.
- For Quick Ratio (X), as of Mar 16, the value is 0.24. This value is below the healthy minimum of 1. It has increased from 0.20 (Mar 15) to 0.24, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 16, the value is 1.65. This value is below the healthy minimum of 4. It has increased from 1.25 (Mar 15) to 1.65, marking an increase of 0.40.
- For Interest Coverage Ratio (X), as of Mar 16, the value is -0.39. This value is below the healthy minimum of 3. It has decreased from -0.14 (Mar 15) to -0.39, marking a decrease of 0.25.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is -0.56. This value is below the healthy minimum of 3. It has decreased from -0.33 (Mar 15) to -0.56, marking a decrease of 0.23.
- For Enterprise Value (Cr.), as of Mar 16, the value is 88.89. It has increased from 87.10 (Mar 15) to 88.89, marking an increase of 1.79.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 1.25. This value is within the healthy range. It has increased from 1.17 (Mar 15) to 1.25, marking an increase of 0.08.
- For EV / EBITDA (X), as of Mar 16, the value is -20.01. This value is below the healthy minimum of 5. It has increased from -56.88 (Mar 15) to -20.01, marking an increase of 36.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 15) to 0.15, marking a decrease of 0.04.
- For Price / BV (X), as of Mar 16, the value is -2.24. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 15) to -2.24, marking a decrease of 3.40.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 15) to 0.15, marking a decrease of 0.04.
- For EarningsYield, as of Mar 16, the value is -1.60. This value is below the healthy minimum of 5. It has decreased from -0.96 (Mar 15) to -1.60, marking a decrease of 0.64.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aplab Ltd:
- Net Profit Margin: -24.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -87.4% (Industry Average ROCE: 8.82%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 2.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.24
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 183 (Industry average Stock P/E: 183)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -16.98
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -24.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Instrumentation & Process Control | Plot No. 12, TTC Industrial Area Thane Belapur Road, Digha, New Mumbai Maharashtra 400708 | response@aplab.com www.aplab.com |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Amrita P Deodhar | Chairperson & Managing Director |
| Mr. S K Hajela | Additional Director |
| Mr. Sanjay N Mehta | Independent Director |
| Mrs. Uma Balakrishnan | Independent Director |
FAQ
What is the intrinsic value of Aplab Ltd?
Aplab Ltd's intrinsic value (as of 04 November 2025) is 33.17 which is 61.87% lower the current market price of 87.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 199 Cr. market cap, FY2025-2026 high/low of 88.8/28.2, reserves of ₹-2.19 Cr, and liabilities of 69.96 Cr.
What is the Market Cap of Aplab Ltd?
The Market Cap of Aplab Ltd is 199 Cr..
What is the current Stock Price of Aplab Ltd as on 04 November 2025?
The current stock price of Aplab Ltd as on 04 November 2025 is 87.0.
What is the High / Low of Aplab Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Aplab Ltd stocks is 88.8/28.2.
What is the Stock P/E of Aplab Ltd?
The Stock P/E of Aplab Ltd is 183.
What is the Book Value of Aplab Ltd?
The Book Value of Aplab Ltd is 7.53.
What is the Dividend Yield of Aplab Ltd?
The Dividend Yield of Aplab Ltd is 0.00 %.
What is the ROCE of Aplab Ltd?
The ROCE of Aplab Ltd is 8.82 %.
What is the ROE of Aplab Ltd?
The ROE of Aplab Ltd is 2.95 %.
What is the Face Value of Aplab Ltd?
The Face Value of Aplab Ltd is 10.0.